Sanofi wins US approval for drug combination to treat multiple myeloma-February 2024-www.financetom.com

Sanofi wins US approval for drug combination to treat multiple myeloma

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sanofi wins US approval for drug combination to treat multiple myeloma

Sep 21, 2024 8:02 PM

Sept 20 - Sanofi won approval for the use of a

drug combination with its Sarclisa infusion to treat certain

types of newly diagnosed multiple myeloma, where it has

previously been used only after standard treatments have failed,

the U.S. Food and Drug Administration said on Friday.

Previous page： News Corp beats fourth-quarter revenue estimates Next page： Linamar Announces Q2 Adjusted Profit Beat, Appoints Jim Jarrell as CEO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

News Corp beats fourth-quarter revenue estimates

Aug 8, 2024

Aug 8 (Reuters) - Media conglomerate News Corp ( NWSA ) beat Wall Street estimates for fourth-quarter revenue on Thursday, helped by digital subscription growth at its Dow Jones business information unit. Revenue in the quarter ended June 30 rose 6%, to $2.58 billion, compared to an estimate of $2.49 billion, according to LSEG data. Part of media mogul Rupert...

Linamar Announces Q2 Adjusted Profit Beat, Appoints Jim Jarrell as CEO

Aug 8, 2024

04:23 PM EDT, 08/08/2024 (MT Newswires) -- Linamar ( LIMAF ) after-hours on Thursday said its profit and revenue rose in the second quarter, while announcing the appointment of Jim Jarrell as chief executive officer. The auto parts manufacturer said its adjusted profit, excluding most one-time items, rose to $188.4 million, or $3.06 per share, from $160.8 million, or $2.61,...

Take-Two Interactive Fiscal Q1 Loss Widens, Revenue Rises; Guidance Updated -- Shares Rise

Aug 8, 2024

04:26 PM EDT, 08/08/2024 (MT Newswires) -- Take-Two Interactive Software ( TTWO ) reported a fiscal Q1 loss late Thursday of $1.52 per diluted share, wider than the loss of $1.22 a year earlier. Analysts polled by Capital IQ expected a loss of $1.37. Revenue for the quarter ended June 30 was $1.34 billion, up from $1.28 billion a year...

Natera Q2 Loss Narrows, Revenue Jumps

Aug 8, 2024

04:26 PM EDT, 08/08/2024 (MT Newswires) -- Natera ( NTRA ) reported a Q2 loss late Thursday of $0.30 per share, narrowing from a loss of $0.97 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.70. Revenue for the quarter ended June 30 was $413.4 million, up from $261.4 million a year ago. Analysts polled by...